2020
$130M
from 12 investors over 12 rounds
Be Biopharma raised $130M on April 14, 2022
Investors: Alta Partners, Takeda UK Limited, Bristol-Myers Squibb, UK, ARCH Venture Partners, Longwood Fund, Atlas Venture and RA Capital Management, L.P.
Be Biopharma raised $52M on October 22, 2020
Investors: Longwood Fund, RA Capital Management, L.P., Takeda UK Limited, Alta Partners and Atlas Venture